Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMNICELL, INC.OMCL · Entity 4666 | Director · CHAIRMAN, CEO | August 15, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMNICELL, INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 511,095.7173 |
Reported balance
After 2026-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-15 · Tax withholding · Disposed 12,350 · Balance 511,095.7173 F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust with Wife | 345,861 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 345,861 F3: Shares held in trust with Mr. Lipps' wife. |
| Common StockSEC Table I · non-derivative | IndirectIn Trust for Children | 8,051 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 8,051 F4: Shares held in trust for the benefit of Mr. Lipps' children. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
F2: The balance is adjusted to reflect 261.6432 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26.
F3: Shares held in trust with Mr. Lipps' wife.
F4: Shares held in trust for the benefit of Mr. Lipps' children.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Invuity, Inc.
Report date October 23, 2018 · Filed October 23, 2018
Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-10-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-10-23 · Disposition to issuer · Disposed 63,452 · Balance 52,231 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Row 2 · 2018-10-23 · Disposition to issuer · Disposed 52,231 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2018-10-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-10-23 · Disposition to issuer · Disposed 7,722 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2024-07-26 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-23 · Disposition to issuer · Disposed 2,054 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.87 · Expires 2021-05-19 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-23 · Disposition to issuer · Disposed 28,900 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price").
F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.
F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.
F4: The shares are held by Lipps Family Ventures, of which the Reporting Person is a Manager.
F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2018 Filed Jun 18, 2018 21:18 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionStock Options NQ (right to Buy) · Derivative | 439 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439 Underlying: Common Stock · 439 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 18, 2018 Filed Jun 18, 2018 21:18 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 439 | $52.00 | $22,828.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,748 F4 · price: The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2018 Filed Jun 18, 2018 21:18 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 21:18 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 10,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008711 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,748 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 23:54 UTC | Invuity, Inc. IVTY · Entity 162847 | GrantCommon Stock | 34,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-039937 · a4.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,683 F1 · shares: Represents an automatic annual restricted stock unit (RSU) award issued pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on June 11, 2019. The Reporting Person has elected to defer the receipt of the shares underlying the RSUs until the earlier of the Reporting Person's separation from service as a director or upon a "change of control" of the Issuer, pursuant to the Issuer's Restricted Stock Unit Deferral Program for Outside Directors. Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 01:15 UTC | Invuity, Inc. IVTY · Entity 162847 | PurchaseCommon Stock | 10,112 | $3.90 | $39,390.28 |
DisclosureSEC source: 0001104659-18-018712 · a4.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,437 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 23:20 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 8,186 | $44.21 | $361,938.26 |
DisclosureSEC source: 0001179110-18-003804 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,323 F5 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $44.2143. The shares sold in between $43.75.50 to $44.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 23:20 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-003804 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,509 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:47 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Option (Right to Buy) · Derivative | 161,678 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-18-001773 · edgar.xml · derivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,678 Underlying: Common Stock · 161,678 shares Expires 2028-02-06 F3 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 17:47 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 55,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001773 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,206 F4 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2019 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2019 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| December 18, 2017 Filed May 2, 2019 00:11 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 35,879 | $51.24 | $1,838,508.13 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 280,613 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F14 · shares: The price reported in Column 4 is the average price of $51.2419. The sold price range between $51.2361 to $51.9333. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This transaction is being reported late due to an inadvertent administrative error. F14 · price: The price reported in Column 4 is the average price of $51.2419. The sold price range between $51.2361 to $51.9333. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This transaction is being reported late due to an inadvertent administrative error. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,400 | $51.75 | $227,700.00 |
DisclosureSEC source: 0001179110-17-015481 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,118 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,033 | $51.75 | $415,707.75 |
DisclosureSEC source: 0001179110-17-015481 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,518 F3 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:31 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Options (right to buy) · Derivative | 10,625 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-17-011961 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 Underlying: Common Stock · 10,625 shares Expires 2024-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:31 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 10,625 | $52.00 | $552,537.19 |
DisclosureSEC source: 0001179110-17-011961 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,551 F4 · price: The price reported in Column 4 is the average price and the shares sold between $52.00 to $52.0050. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:31 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 10,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-011961 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 09, 2017 Filed Aug 15, 2017 01:26 UTC | Invuity, Inc. IVTY · Entity 162847 | PurchaseCommon Stock | 20,000 | $6.27 | $125,426.00 |
DisclosureSEC source: 0001104659-17-051907 · a4.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,325 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.1500 to $6.2950. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 22:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Options (right to buy) · Derivative | 40,000 | $0.00 Strike: $12.48 | $0.00 |
DisclosureSEC source: 0001179110-17-010912 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2020-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 22:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 40,000 | $49.76 | $1,990,396.00 |
DisclosureSEC source: 0001179110-17-010912 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,551 F4 · price: The price reported in Column 4 is the average price and the shares sold between $49.10 to $50.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 22:48 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-010912 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 22:22 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Options (right to buy) · Derivative | 37,500 | $0.00 Strike: $17.29 | $0.00 |
DisclosureSEC source: 0001179110-17-010798 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 22:22 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 37,500 | $46.00 | $1,725,000.00 |
DisclosureSEC source: 0001179110-17-010798 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,551 F4 · price: The price reported in Column 4 is the exact price $46.00 for all the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 28, 2017 Filed Jul 28, 2017 22:22 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-010798 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 15:12 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 31,527 | $42.87 | $1,351,657.07 |
DisclosureSEC source: 0001179110-17-009316 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,701 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the Average price, the price range is between $42.55 to $43.5499 for all the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 22:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,398 | $42.95 | $188,894.10 |
DisclosureSEC source: 0001179110-17-009118 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,551 F5 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 22:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 8,033 | $42.95 | $345,017.35 |
DisclosureSEC source: 0001179110-17-009118 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,949 F5 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 22:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Options (right to buy) · Derivative | 32,600 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001179110-17-009118 · edgar.xml · derivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,600 Underlying: Common Stock · 32,600 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 22:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 32,600 | $43.00 | $1,401,800.00 |
DisclosureSEC source: 0001179110-17-009118 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,982 F4 · price: The price reported in Column 4 is the Exact price for all the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 22:09 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 32,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-009118 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 21:50 UTC | Invuity, Inc. IVTY · Entity 162847 | GrantCommon Stock | 17,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-039264 · a4.xml · nonDerivative · entry 1 LIPPS RANDALL A · CIK 0001227556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,325 F1 · shares: Represents an automatic annual restricted stock unit (RSU) award issued pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on June 13, 2018. The Reporting Person has elected to defer the receipt of the shares underlying the RSUs until the earlier of the Reporting Person's separation from service as a director or upon a "change of control" of the Issuer, pursuant to the Issuer's Restricted Stock Unit Deferral Program for Outside Directors. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 21:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Options (right to buy) · Derivative | 9,900 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001179110-17-008671 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Common Stock · 9,900 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 21:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 9,900 | $43.00 | $425,700.00 |
DisclosureSEC source: 0001179110-17-008671 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,982 F4 · price: The price reported in Column 4 is the Exact price for all the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 21:50 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 9,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008671 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 15:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionNon-Qualified Options (right to buy) · Derivative | 18,200 | $0.00 Strike: $14.10 | $0.00 |
DisclosureSEC source: 0001179110-17-006203 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,200 Underlying: Common Stock · 18,200 shares Expires 2021-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 15:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | SaleCommon Stock | 18,200 | $41.00 | $746,200.00 |
DisclosureSEC source: 0001179110-17-006203 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,982 F4 · price: The price reported in Column 4 is the Exact price for all the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 15:23 UTC | OMNICELL, INC. OMCL · Entity 4666 | Exercise / conversionCommon Stock | 18,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006203 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 22:13 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 4,902 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-004336 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,982 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:25 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantStock Option (Right to Buy) · Derivative | 134,160 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-17-002192 · edgar.xml · derivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,160 Underlying: Common Stock · 134,160 shares Expires 2027-02-08 F4 · shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:25 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 54,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002192 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,705 F5 · shares: The Performance-based restricted stock unit awards vest as to 25% of the shares on the date of the Compensation Committee meeting in 2018 when the Committee reviews the performance-based metrics and determines if they were met or not with the remaining shares vesting on a semi-annual basis over a period of thirty-six months commencing on June 15, 2018 if the Company meets certain stock performance objectives compared to the NASDAQ Healthcare Index. The actual number of performance based stock awards that vest may be 0%, 50% or 100% of the numbers reflected above, depending upon the Company's performance. Read SEC document |
| February 08, 2017 Filed Feb 11, 2017 00:25 UTC | OMNICELL, INC. OMCL · Entity 4666 | GrantCommon Stock | 16,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-002192 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,355 F3 · shares: Restricted Stock Units shall vest semiannually on 6/15 and 12/15 for a period of 4 years. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 22:42 UTC | OMNICELL, INC. OMCL · Entity 4666 | Tax withholdingCommon Stock | 11,866 | $33.90 | $402,257.40 |
DisclosureSEC source: 0001179110-16-033146 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President, and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,034 F3 · shares: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.